GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › MDAI growth analysis
Growth stock analysis · updated 2026-07-28

Spectral AI, Inc. Class A Common Stock (MDAI) growth stock analysis

Is Spectral AI, Inc. Class A Common Stock a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
7
Growth score
18
RS rating
#4,588
Rank
0/6
Traits passed
7/99
Growth score · 4588th of 4,892 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about MDAI

As of the 2026-07-28 close, MDAI scores 7 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 4588th of 4,892 rated US stocks, the top 94% of the market.

Its strongest trait is S (supply & demand) at 42, and its weakest is A (annual earnings growth) at 0. MDAI clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, MDAI carries a lagging Relative Strength rating of 18, meaning it has outperformed about 18% of the market over the past year.

Underneath the score: quarterly earnings down 200% year over year, sales down 41%, trading 43% below its 52-week high.

MDAI growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
39
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
10
S
Supply & demand
volume behind the move vs. share supply
42
L
Leader or laggard
Relative Strength within its group
21
I
Institutional sponsorship
fund accumulation and 13F ownership
6

Is MDAI a growth stock?

Not right now by CANSLIM

On today’s data MDAI does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than MDAI

The stocks ranking above MDAI today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 MDAI price history & buy range

Where MDAI sits in its base, its 52-week path, and the trait trend over the past year.

Open the full MDAI profile →

See where MDAI ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

MDAI as a growth stock, frequently asked

Is MDAI a good growth stock?

Not right now by CANSLIM. On today’s data MDAI does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is MDAI's growth score?

Spectral AI, Inc. Class A Common Stock (MDAI) scores 7 out of 99 on our growth-stock rating as of the 2026-07-28 close, ranking 4588th of 4,892 rated US stocks.

Does MDAI have strong earnings growth?

MDAI's most recent quarterly earnings were down about 200% year over year, with sales down 41%.

How strong is MDAI's price performance?

MDAI has a Relative Strength rating of 18, meaning it has outperformed roughly 18% of the US market over the trailing year.

Where can I see MDAI's full analysis?

Create a free Growth Stock Analyzer account to see where MDAI ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Surgical & Medical Instruments & Apparatus